|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.540
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.531
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.516
|
Rat |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.501
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.396
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.389
|
Rat |
|
|
gene silencing
|
GO:0016458 |
38 |
0.373
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.360
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.312
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.294
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.290
|
Rat |
|
|
histone modification
|
GO:0016570 |
159 |
0.287
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.276
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.272
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.260
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.258
|
Rat |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.253
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.216
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.206
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.199
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.192
|
Rat |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.191
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.188
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.187
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.184
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.180
|
Rat |
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.172
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.166
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.166
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.156
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.154
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.148
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.146
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.143
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.137
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.137
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.136
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.130
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.128
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.126
|
Rat |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.120
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.120
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.120
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.112
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.111
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.109
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.106
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.106
|
Rat |
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.105
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.105
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.102
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.101
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.098
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.098
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.097
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.095
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.093
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.092
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.092
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.092
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.091
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.090
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.087
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.087
|
Rat |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.087
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.085
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.084
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.082
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.082
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.082
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.081
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.080
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.079
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.076
|
|
|
|
negative regulation of ripoptosome assembly involved in necroptotic process
|
GO:1902443 |
3 |
0.076
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.075
|
Rat |
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.073
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.072
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.071
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.071
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.070
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.069
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.068
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.067
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.065
|
|
|
|
negative regulation of necroptotic process
|
GO:0060546 |
9 |
0.065
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.065
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.063
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.063
|
Rat |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.063
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.062
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.061
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.061
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.059
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.059
|
Rat |
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.058
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.058
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.057
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.057
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.056
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.056
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.056
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.055
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.054
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.053
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.053
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.053
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.052
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.052
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.052
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.051
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.050
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.049
|
|
|
|
translation
|
GO:0006412 |
93 |
0.049
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.048
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.047
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.047
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.047
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.047
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.047
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.046
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.046
|
Rat |
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.046
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.046
|
Rat |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.045
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.045
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.045
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.044
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.044
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
Rat |
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.043
|
|
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
4 |
0.043
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.043
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.042
|
|
|
|
negative regulation of necrotic cell death
|
GO:0060547 |
11 |
0.042
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.042
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.041
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.041
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.041
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.040
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.040
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.039
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.039
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.039
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.038
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.038
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.038
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.038
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.037
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.037
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.037
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.037
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.035
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.035
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.034
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.034
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.034
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.034
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
Rat |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.034
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.034
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.034
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.033
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.033
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.033
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.032
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.032
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.032
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.031
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.030
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.030
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.030
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.030
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.030
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.029
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.029
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.029
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.029
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.029
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.029
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.029
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.028
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.028
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.028
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.028
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.028
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.028
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.028
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.027
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.027
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.026
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.025
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.025
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.025
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.025
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.025
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.025
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.024
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.024
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.024
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.024
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.024
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.024
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.024
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.024
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.024
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.024
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.023
|
Rat |
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.023
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.023
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.023
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.023
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.023
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.023
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.023
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.022
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.022
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.022
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.022
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.022
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.022
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.022
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.022
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
Rat |
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.021
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.021
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.021
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.021
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.020
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.020
|
Rat |
|
|
defense response to virus
|
GO:0051607 |
68 |
0.020
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.020
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.020
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.020
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.020
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.020
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.020
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.020
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.020
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.020
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.020
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.019
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.019
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.019
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.019
|
|
|
|
regulation of antibacterial peptide production
|
GO:0002786 |
1 |
0.019
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.018
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.018
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.018
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.018
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.018
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.018
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.018
|
|
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
5 |
0.018
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.018
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.018
|
Rat |
|
|
activation of jun kinase activity
|
GO:0007257 |
15 |
0.018
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.018
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.018
|
|
|
|
cytoplasmic mrna processing body assembly
|
GO:0033962 |
6 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
25 |
0.017
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.017
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.017
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.017
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.017
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.017
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.017
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.017
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.017
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.016
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.016
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
25 |
0.016
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.016
|
|
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
4 |
0.016
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.016
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.016
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.016
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.016
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.016
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.016
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.015
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.015
|
|
|
|
interleukin 12 production
|
GO:0032615 |
32 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.015
|
Rat |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
ripoptosome assembly involved in necroptotic process
|
GO:1901026 |
6 |
0.015
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.015
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.015
|
Rat |
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.015
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.015
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.015
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.015
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.015
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.015
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.015
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.015
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.015
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.015
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.015
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.014
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.014
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.014
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.014
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.014
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.014
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.014
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.014
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
|
positive regulation of interleukin 12 production
|
GO:0032735 |
21 |
0.014
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.014
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.014
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.014
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.014
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.014
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.014
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.014
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.014
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.014
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.014
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.014
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.014
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.013
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.013
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.013
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.013
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.013
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.013
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.013
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.013
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.013
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.013
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.013
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.013
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.013
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.013
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.013
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.013
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.013
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.013
|
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.012
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.012
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.012
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.012
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.012
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.012
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.012
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.012
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.012
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.012
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
14 |
0.012
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.012
|
|
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.012
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.012
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.012
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.012
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.012
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.012
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.012
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.012
|
|
|
|
clathrin coat assembly
|
GO:0048268 |
2 |
0.012
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.012
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.012
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.011
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.011
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.011
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.011
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.011
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.011
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.011
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.011
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.011
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.011
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.011
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.011
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.011
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.011
|
|
